CS logo
small CS logo
Orlando Regional Medical Center

Orlando, Florida, United States
Hospital in Orlando, Florida
52 W Underwood St, Orlando, FL 32806
808 Beds

About Orlando Regional Medical Center


Orlando Regional Medical Center is an 808-bed tertiary hospital in downtown Orlando, Florida designed by HKS, Inc. and Walter P Moore. It is the flagship of the Orlando Health system.
There are 808 beds in Orlando Regional Medical Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boston Scientific Corporation
7
Abbott Medical Devices
4
Major Extremity Trauma Research Consortium
3
Cook Group Incorporated
2
Cumberland Pharmaceuticals
2
Orlando Regional Medical Center
2
Pfizer
2
Phathom Pharmaceuticals, Inc.
2
Wake Forest University Health Sciences
2
3M
1
Alexion
1
Total Rows: 28

Clinical Trials at Orlando Regional Medical Center


During the past decade, Orlando Regional Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 18 clinical trials were completed, i.e. on average, 163.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122332222001111224422331122Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carotid Revascularization Endarterectomy Versus Stenting Trial
2000-12-01
2016-12-01
Completed
2,502
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
2004-07-01
2005-10-01
Completed
4,000
A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
2005-05-01
2007-01-01
Terminated
658
Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
2005-03-01
2014-02-01
Completed
474
RethinQ Study - Evaluating Pacing in Heart Failure Patients
2005-07-01
2007-07-01
Completed
250
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)
2009-05-01
2015-10-01
Completed
7,057
Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients
2007-11-01
2009-05-01
Completed
61
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
2007-12-01
2010-08-01
Completed
28

Rows per page:

1–45 of 45

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Orlando Regional Medical Center" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "Major Extremity Trauma Research Consortium" with 3 trials sponsored, "Cook Group Incorporated" with 2 trials sponsored and "Cumberland Pharmaceuticals" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Regional Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoston Scientific Corporation: 7Boston Scientific Corporation: 7Abbott Medical Devices: 4Abbott Medical Devices: 4Major Extremity TraumaResearch Consortium: 3Major Extremity TraumaResearch Consortium: 3Cook Group Incorporated: 2Cook Group Incorporated: 2Cumberland Pharmaceuticals: 2Cumberland Pharmaceuticals: 2Orlando RegionalMedical Center: 2Orlando RegionalMedical Center: 2Pfizer: 2Pfizer: 2PhathomPharmaceuticals, Inc.: 2PhathomPharmaceuticals, Inc.: 2Wake Forest UniversityHealth Sciences: 2Wake Forest UniversityHealth Sciences: 23M: 13M: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Heart, Lung,and Blood Institute(NHLBI): 2National Heart, Lung,and Blood Institute(NHLBI): 2United StatesDepartment of Defense:2United StatesDepartment of Defense:2Abbott Medical Devices: 1Abbott Medical Devices: 1Agency for HealthcareResearch and Quality(AHRQ): 1Agency for HealthcareResearch and Quality(AHRQ): 1Baxter HealthcareCorporation: 1Baxter HealthcareCorporation: 1Cook Japan Incorporated: 1Cook Japan Incorporated: 1EKOS Corporation: 1EKOS Corporation: 1Florida InternationalUniversity: 1Florida InternationalUniversity: 1Forest Laboratories: 1Forest Laboratories: 1MED Institute, Incorporated: 1MED Institute, Incorporated: 1

Clinical Trials Conditions at Orlando Regional Medical Center


According to Clinical.Site data, the most researched conditions in "Orlando Regional Medical Center" are "Coronary Artery Disease" (6 trials), "Heart Failure" (5 trials), "Pulmonary Embolism" (3 trials), "Bradycardia" (2 trials) and "Burns" (2 trials). Many other conditions were trialed in "Orlando Regional Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Orlando Regional Medical Center


Most popular intervention types in "Orlando Regional Medical Center" are "Device" (21 trials), "Drug" (12 trials), "Procedure" (6 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Vonoprazan" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "ACURATE Prime™ Transfemoral TAVR System XL" (1 trials) and "ACURATE neo2™ Transfemoral TAVR System" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Orlando Regional Medical Center


The vast majority of trials in "Orlando Regional Medical Center" are 45 trials for "All" genders.

Clinical Trials Status at Orlando Regional Medical Center


Currently, there are NaN active trials in "Orlando Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Orlando Regional Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Orlando Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 15Not Applicable: 15Phase 3: 14Phase 3: 14Phase 2: 2Phase 2: 2Phase 4: 2Phase 4: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 36Completed: 36Active, not recruiting: 3Active, not recruiting: 3Terminated: 3Terminated: 3Recruiting: 2Recruiting: 2Withdrawn: 1Withdrawn: 1